BOTHELL, Wash., March 2, 2015 /PRNewswire/ -- BioLife
Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer
and marketer of proprietary clinical grade hypothermic storage and
cryopreservation freeze media and precision thermal shipping
products for cells and tissues ("BioLife" or the "Company"),
today announced that Seattle Business Magazine has named the
Company its 2015 Silver Awardee for Achievement in Medical
Technology.
Seattle Business Magazine Associate Publisher Michael Romoser described the environment for
the awards program by stating, "While change in the health care
business is not new, the pace of it is accelerating. Honorees
in the 2015 Leaders in Health Care Awards program are at the
forefront of unprecedented industry change as innovative
problem solvers and inspirational leaders. Among this year's
19 honorees are people who lead some of the largest and most
important health care organizations in the region — be they
hospitals, physician groups, research institutions or community
programs. Their leadership is fostering creative change to
organizations that are being challenged to raise the bar on the
quality of patient safety and service while bringing new efficiency
to their operations."
Judges for the 2015 Leaders in Health Care Awards included:
Leo Greenawalt, former president,
Washington State Hospital
Association
Mary McWilliams, former executive
director, Washington Health Alliance
Chris Rivera, president and CEO,
Washington Biotechnology & Biomedical Association
Roger Stark, M.D., health care
policy analyst, Washington Policy Center
Mike Rice, BioLife President
& CEO, stated, "This award is great recognition for our entire
team. Every team member really understands the positive
impact our biopreservation tools can have on the development and
commercialization of life saving cell and tissue-based regenerative
medicine products and therapies. Our culture of teamwork,
quality, and customer service is very special and I'm very honored
to lead such a dedicated team."
About BioLife Solutions
BioLife Solutions develops, manufactures and markets hypothermic
storage and cryopreservation solutions and precision thermal
shipping products for cells, tissues, and organs. BioLife also
performs contract aseptic media formulation, fill, and finish
services. The Company's proprietary HypoThermosol® and
CryoStor® platform of solutions are highly valued in the
biobanking, drug discovery, and regenerative medicine markets.
BioLife's biopreservation media products are serum-free and
protein-free, fully defined, and are formulated to reduce
preservation-induced cell damage and death. BioLife's
enabling technology provides commercial companies and clinical
researchers significant improvement in shelf life and
post-preservation viability and function of cells, tissues, and
organs. For more information please visit
www.biolifesolutions.com, and follow BioLife on Twitter.
This press release contains forward-looking statements,
including, but not limited to, statements concerning the company's
anticipated business and operations, the potential utility of and
market for its products and services, potential revenue growth and
market expansion, new products, and third party projections
regarding the future market for regenerative medicine and cold
chain packaging and instrumentation services. All statements other
than statements of historical fact are statements that could be
deemed forward-looking statements. These statements are based on
management's current expectations and beliefs and are subject to a
number of risks, uncertainties and assumptions that could cause
actual results to differ materially from those described in the
forward-looking statements, including among other things,
uncertainty regarding market adoption of products; uncertainty
regarding third party market projections; market volatility;
competition; litigation; reliance upon SAVSU for completing the
development and manufacturing of biologistex CCM's products; and
those other factors described in our risk factors set forth in our
filings with the Securities and Exchange Commission from time to
time, including our Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q. We undertake no obligation to update the
forward-looking statements contained herein or to reflect events or
circumstances occurring after the date hereof, other than as may be
required by applicable law.
Media &
Investor Relations
|
|
|
Daphne
Taylor
|
|
|
Senior Vice
President, Chief Financial Officer
|
|
|
(425)
402-1400
|
|
|
dtaylor@biolifesolutions.com
|
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biolife-solutions-wins-washington-state-2015-silver-award-for-achievement-in-medical-technology-from-seattle-business-magazine-300043089.html
SOURCE BioLife Solutions, Inc.